Results 11 to 20 of about 129 (105)
КЛОПИДОГРЕЛ ПРИ ПЛАНОВОЙ РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА
, 2016 The article focuses on the practical issues of selective revascularization of myocardium, including the specifics of procedure and patients characteristics, whom this intervention is at most indicated.
Наталья Вадимовна Теплова
semanticscholar +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance in percutaneous coronary intervention (PCI), to identify clinical risk factors of resistance development, to study effects of concomitant therapy on ...
V. A. Sulimov, E. V. Moroz
doaj +1 more source
МОЖЕТ ЛИ КЛОПИДОГРЕЛ В ПОЛНОЙ МЕРЕ ЗАМЕНИТЬ ВАРФАРИН И ДАБИГАТРАН ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ
, 2013 Commentary on the paper “Age and effectiveness and safety of various antithrombotic therapy variants in patients with nonvalvular atrial fibrillation” by Shevelev V. I. and Kanorskyi S. G. (Cardiovascular Therapy and Prevention 2013;12 (1):46–53).
А. Б. Сумароков
semanticscholar +1 more source
Патология кровообращения и кардиохирургия, 2019 Актуальность. У части пациентов наблюдаются изменения активности клопидогрела за счет полиморфных вариантов rs4244285(*2), rs4986893 (*3), rs12248560 (*17) в гене цитохрома CYP2C19, влияющих на метаболизм.
Е. Зеленская +6 more
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Concomitant administration of clopidogrel and proton pump inhibitors (PPI), the possible influence of PPI on the effectiveness of clopidogrel often raises questions among practitioners.
S. Yu. Martsevich, A. Yu. Suvorov
doaj +1 more source
A clinical case of acute coronary syndrome in patients with type 2 diabetes
Медицинский совет, 2015 The article reviews a clinical cases of acute coronary syndrome in a patient with type 2 diabetes (T2D). The causes of progression of atherosclerosis in patients with T2D are considered which leads to myocardial ischemia against a background of ...
S. V. Kakorin, E. N. Kononets
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Aim. Carriership of CYP2C19*2 allelic variant and reduced CYP3A4 activity can affect the formation of clopidogrel’s active metabolite and, respectively, its antiplatelet effect.
K. B. Mirzaev +4 more
doaj +1 more source
Acta Biomedica Scientifica, 2023 Background. In our previously published studies, we demonstrated a high hemostatic activity of a low dose of exogenous fibrin monomer during its systemic administration in a model of dosed liver injury with preliminary inhibition of platelet aggregation.
V. M. Vdovin +6 more
doaj +1 more source
Атеротромбоз, 2014 Статья посвящена обсуждению вопросов приверженности к применению двойной антитромбоцитарной терапии (ДАТ) у пациентов, перенесших острый коронарный синдром (ОКС) или перенесших коронарное стентирование.
doaj +1 more source
EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE
Рациональная фармакотерапия в кардиологии, 2015 Evaluation of platelet function with subsequent modification of antiplatelet therapy regimen is one of the areas of personalized medicine. Analysis of the causes of inadequate antiplatelet action of clopidogrel, the association of residual platelet ...
K. B. Mirzaev +2 more
doaj +1 more source